Dyne Therapeutics Announces FDA Review of Biologics License Application for Zeleciment Rostudir – July 2026 8-K Filing
Dyne Therapeutics, Inc. Files Form 8-K: Key Developments and...
Sign in to continue:
Dyne Therapeutics, Inc. Files Form 8-K: Key Developments and...
Gates Industrial Corporation Ltd. Files Form 8-K: Redomicili...
Strive, Inc. (NASDAQ: ASST, SATA) Files Form 8-K: Key Update...
VPR Brands, LP. - 8-K Filing Analysis VPR Brands, LP. Fi...
Strategy Inc. (Formerly MicroStrategy): Key Updates from Jul...
MainStreet Bancshares, Inc. Posts Strong Q2 2026 Results: Ne...
Solstice Advanced Materials to Acquire Element Solutions: In...
HA Sustainable Infrastructure Capital, Inc. - Investor Repor...
Dynex Capital, Inc. Reports Strong Q2 2026 Earnings: Book Va...
Kalaris Therapeutics, Inc. Announces Key Executive Changes: ...